InMode Ltd. (NASDAQ:INMD) Stock Holdings Lowered by Principal Financial Group Inc.

Principal Financial Group Inc. lowered its stake in InMode Ltd. (NASDAQ:INMD) by 8.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 86,901 shares of the healthcare company’s stock after selling 7,629 shares during the period. Principal Financial Group Inc. owned approximately 0.10% of InMode worth $1,473,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of INMD. DGS Capital Management LLC purchased a new position in shares of InMode in the third quarter worth approximately $182,000. Franklin Resources Inc. grew its position in InMode by 4.6% during the 3rd quarter. Franklin Resources Inc. now owns 17,559 shares of the healthcare company’s stock worth $292,000 after purchasing an additional 768 shares in the last quarter. Tidal Investments LLC raised its stake in InMode by 4.6% during the 3rd quarter. Tidal Investments LLC now owns 71,039 shares of the healthcare company’s stock valued at $1,204,000 after purchasing an additional 3,140 shares during the period. Virtu Financial LLC purchased a new stake in shares of InMode in the third quarter valued at $219,000. Finally, Geode Capital Management LLC boosted its position in shares of InMode by 0.6% in the third quarter. Geode Capital Management LLC now owns 1,101,951 shares of the healthcare company’s stock worth $18,678,000 after buying an additional 6,282 shares during the period. Institutional investors and hedge funds own 68.04% of the company’s stock.

Analysts Set New Price Targets

INMD has been the subject of several research analyst reports. Needham & Company LLC reissued a “hold” rating on shares of InMode in a research note on Thursday, October 31st. BTIG Research started coverage on shares of InMode in a research report on Thursday, October 17th. They issued a “buy” rating and a $25.00 price target for the company. Finally, Barclays decreased their price target on shares of InMode from $29.00 to $27.00 and set an “overweight” rating for the company in a report on Monday, October 14th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $22.60.

InMode Stock Performance

Shares of NASDAQ INMD opened at $17.01 on Friday. The business has a 50 day simple moving average of $18.17 and a 200 day simple moving average of $17.35. InMode Ltd. has a 52 week low of $14.87 and a 52 week high of $26.80. The stock has a market cap of $1.43 billion, a price-to-earnings ratio of 9.19 and a beta of 2.12.

InMode Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.